DOW JONES21,048.68-868.48 -3.96%
S&P 5002,474.28-110.31 -4.27%
NASDAQ7,394.37-305.73 -3.97%

Cantor Fitzgerald Assumes Pacific Biosciences at Overweight, Announces $5 Price Target

Cantor Fitzgerald analyst Alethia Young assumes Pacific Biosciences (NASDAQ:PACB) with a Overweight rating and a $5 price target.

Benzinga · 03/09/2020 14:48

Cantor Fitzgerald analyst Alethia Young assumes Pacific Biosciences (NASDAQ:PACB) with a Overweight rating and a $5 price target.